Survival and Prognostic Factors for AIDS and Non-AIDS Patients with Non-Hodgkin’s Lymphoma in Bahia, Brazil: A Retrospective Cohort Study

Table 2

Predictive factors of overall survival for patients with NHL, according to HIV serostatus.

Characteristics	HIV positive			HIV negative
	𝑁	Mean (months)	IC	𝑁	Mean; (months)	IC	𝑃 value
ECOG
0-1	11	57	24.4–88.7	50	77	62.3–90.8	0.187
2-3	8	5	1.7–7.5	6	28	1.9–54.5	0.175
IPI
0-1	3	80	22.4–137.6	27	94	77.8–110.9	0.680
2-3	16	25	5.0–45.5	29	51	33.2–69.2	0.017
Bulky disease
Yes	8	14	0–28.6	20	53	29.7–76.0	0.004
No	19	52	28.0–75.0	41	81	65.7–97.1	0.036
LDH
Normal	5	74	28.5–119.1	23	83	69.4–108.4	0.605
Elevated	18	19	3.3–34.3	33	62	45.1–82.1	<0.001
Bone marrow infiltration
Yes	5	5	0.3–9.7	9	36	14.5–57.8	0.001
No	18	54	29.5–78.3	42	84	68.7–99.5	0.026
Disease stage
1 or 2	6	69	29.0–108.6	27	97	80.2–113.2	0.184
3 or 4	21	31	12.9–49.0	34	51	33.7–67.4	0.067
Absolute lymphocyte count (>1,000/mm³)
Yes	16	49	22.5–75.2	40	73	57.4–89.6	0.064
No	6	6	2.4–10.2	17	53	28.8–78.6	0.011
B symptoms
Yes	24	34	15.5–51.5	42	64	47.5–79.9	0.007
No	4	70	21.1–117.9	19	91	69.2–112.8	0.411